Jeffrey Poulton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey Poulton
Jeffrey Poulton is recorded as CFO at Alnylam Pharmaceuticals, Inc. (ALNY). The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $6,863,800 for Jeffrey Poulton in fiscal 2025, including a base salary of $724,400. Disclosed compensation is on record for 7 fiscal years. Jeffrey Poulton has spoken on 26 earnings calls across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on July 30, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $724,400 | $6,863,800 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $687,400 | $3,792,780 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $651,900 | $3,224,360 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $604,500 | $2,421,630 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $569,200 | $2,798,175 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Financial Officer (principal financial officer) | $556,800 | $2,492,968 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, ChiefFinancial Officer (principal financial officer) | $254,808 | $5,877,416 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.